Претраживање
Приказ резултата 1-10 од 22
Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia
(Pergamon-Elsevier Science Ltd, Oxford, 2009)
Introduction: It is considered that high plasma levels of procarboxypeptidase U (proCPU or TAFI) can promote the development of thrombosis, but data comparing proCPU levels in thrombophilia carriers and healthy subjects ...
Evaluation of endogenous thrombin potential among patients with antithrombin deficiency
(Pergamon-Elsevier Science Ltd, Oxford, 2018)
Thrombin generation, D-dimer and protein S in normal uncomplicated pregnancy
(Pergamon-Elsevier Science Ltd, Oxford, 2015)
The presence of prothrombotic mutations and a higher FVIII activity contribute to thrombosis development during the breast cancer treatment
(Pergamon-Elsevier Science Ltd, Oxford, 2014)
Can anticoagulant therapy improve the outcome of pregnancy in thrombophilic women?
(Pergamon-Elsevier Science Ltd, Oxford, 2011)
Combined severe factor XII deficiency and homozygous factor V Leiden mutation in a patient with venous thrombosis
(Pergamon-Elsevier Science Ltd, Oxford, 2002)
Risk factors for thrombosis in acute promyelocytic leukemia
(Pergamon-Elsevier Science Ltd, Oxford, 2014)
Poor pregnancy outcome in women with homozygous type-II HBS antithrombin deficiency
(Pergamon-Elsevier Science Ltd, Oxford, 2014)
Pregnancy loss and thrombotic complications during pregnancy and puerperium in women with coinheritance of factor V Leiden and FII G20210A mutation
(Pergamon-Elsevier Science Ltd, Oxford, 2005)
Assessment of risk factors for venous thromboembolism in women with breast carcinoma
(Pergamon-Elsevier Science Ltd, Oxford, 2012)